Drug Prices
Watch the video
The timing of the AHA Annual Membership Meeting presents a 鈥渞eal opportunity to talk with your members of Congress about what you are doing back home,鈥 specifically how hospitals are improving value and affordability, coping with escalating drug prices and working at the front鈥
AHA President and CEO Rick Pollack and AARP CEO Jo Ann Jenkins today authored an OpEd in The Hill discussing the skyrocketing costs of prescription drugs and what they mean for patients and our health care system.
The number of U.S. retail opioid prescriptions fell by 10.2% in 2017, including a 16.1% decline in high-dose prescriptions, according to a report released today by the IQVIA Institute for Human Data Science.
Also in this week鈥檚 roundup: Maine hospital named for Barbara Bush recognizes her passing and University of Virginia Medical Center uses app to communicate with non-English speaking patients.
Coastal Meds LLC, which compounds drugs as an outsourcing facility, has voluntarily recalled all of its products marketed as sterile due to visible particles in some of the drug vials for injection.
The price of the 20 most prescribed brand-name drugs in the Medicare Part D program increased an average 12% per year between 2012 and 2017, about 10 times more than the average annual rate of inflation.
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions Re: Perspectives on the 340B Drug Pricing Program
The Campaign for Sustainable Rx Pricing released a digital and television ad urging Congress to pass the Creating and Restoring Equal Access to Equivalent Samples Act to lower drug prices.
Also in this week鈥檚 roundup: Intermountain Healthcare鈥檚 efforts to extend medical services outside of traditional hospital walls; and a new survey showing more patients wanting access to digital health care.
WASHINGTON, DC (March 1, 2018) 鈥 Hospitals of all kinds provide a full range of benefits to their communities. In a new analysis released today, the 黑料正能量 Associati